Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New perspectives in lung cancer.5. New drugs in lung cancer.

× No keyword cloud information.

48 in total

1. Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Authors: C Rose; T E Lad; L J Kilton; J Schor; S T Rosen; A H Rossof; R R Blough; C M Johnson
Journal: Invest New Drugs Date: 1990-02 Impact factor: 3.850

2. Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.

Authors: D S Ettinger
Journal: J Clin Oncol Date: 1990-03 Impact factor: 44.544

3. Treatment of malignant melanoma with camptothecin (NSC-100880).

Authors: J A Gottlieb; J K Luce
Journal: Cancer Chemother Rep Date: 1972-02

4. Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.

Authors: S C Yang; L Owen-Schaub; A Mendiguren-Rodriguez; E A Grimm; W K Hong; J A Roth
Journal: J Thorac Cardiovasc Surg Date: 1990-01 Impact factor: 5.209

Review 5. Carboplatin in small cell lung cancer.

Authors: N Thatcher; M Lind
Journal: Semin Oncol Date: 1990-02 Impact factor: 4.929

6. Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.

Authors: M Blackstein; E A Eisenhauer; R Wierzbicki; S Yoshida
Journal: J Clin Oncol Date: 1990-03 Impact factor: 44.544

7. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.

Authors: W K Evans; E A Eisenhauer; Y Cormier; J Ayoub; R Wierzbicki; F Laberge; F A Shepherd
Journal: J Clin Oncol Date: 1990-03 Impact factor: 44.544

8. Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.

Authors: P Drings; I U Günther; U Gatzemeier; W Berdel; M Stahl; E Salewski; L Edler
Journal: Onkologie Date: 1990-06

9. Phase II study of lonidamine in non-small cell lung cancer: final report.

Authors: O Kokron; S Maca; M De Gregorio; G B Ciottoli
Journal: Br J Cancer Date: 1990-02 Impact factor: 7.640

10. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research.

Authors: R L Souhami; K Law
Journal: Br J Cancer Date: 1990-04 Impact factor: 7.640